Isabel Bahm is a Vice President in the EQT Life Sciences team. Isabel worked for LSP from 2018 until 2022, when LSP joined forces with EQT and was renamed EQT Life Sciences.
Prior to joining LSP, Isabel worked as an Analyst at M Ventures in Amsterdam, Netherlands.
Isabel holds a PhD in stem cell and developmental biology from the University College London and a Dipl. in biology from the University of Freiburg.